HLA-G COMPOSITIONS AND METHODS OF USE THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12788623

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

It has been discovered that HLA-G dimers are potent ligands of ILT2 and ILT4 on immune cells and enhance signal transduction through ILT2 and ILT4. Enhanced signal transduction through ILT-2, ILT-4 or both down-regulates the biological activity of T cells and dendritic cells. HLA-G compositions including HLA-G dimers are provided that are useful for modulating activity of immune cells. Preferred compositions include microparticles having HLA-G dimers on the surface of the microparticles. The microparticles optionally include a targeting moiety to target the microparticles to specific immune cells. In a preferred embodiment the microparticles are targeted to T cells or dendritic cells expressing ILT2 or both ILT2 and ILT4, respectively. The HLA-G dimer can include any HLA-G protein that is capable of forming a dimer. Preferred HLA-G proteins include HLA-G1 and HLA-G5. In certain embodiments the microparticles include dimers of HLA-G1 and HLA-G5.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC1120 15TH STREET AUGUSTA GA 30912

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Horuzsko, Anatolij Evans, US 1 4
Kaminski, Joseph Evans, US 10 167

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation